{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "170320",
  "DateCompleted": {
    "Year": "1975",
    "Month": "12",
    "Day": "12"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "05",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0021-9746",
      "JournalIssue": {
        "Volume": "28",
        "Issue": "9",
        "PubDate": {
          "Year": "1975",
          "Month": "Sep"
        }
      },
      "Title": "Journal of clinical pathology",
      "ISOAbbreviation": "J Clin Pathol"
    },
    "ArticleTitle": "Lobular carcinoma of the breast: a special variant of mucin-secreting carcinoma.",
    "Pagination": {
      "StartPage": "711",
      "EndPage": "716",
      "MedlinePgn": "711-6"
    },
    "Abstract": {
      "AbstractText": [
        "There is currently much speculation over the precise nature of lobular carcinoma in-situ of the breast and its significance. Histochemical study shows that it is rich in sialomucin. This has a characteristic intracellular distribution which distinghishes lobular carcinoma in-situ from cancerization of lobules. The same histochemical features are seen in the infiltrative phase of the tumour. These findings invalidate the concept that it is a myoepithelial-cell tumour. Practical applications of the distinctive pattern of mucin secretion are discussed."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gad",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Azzopardi",
        "ForeName": "J G",
        "Initials": "JG"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Clin Pathol",
    "NlmUniqueID": "0376601",
    "ISSNLinking": "0021-9746"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Mucins"
    },
    {
      "RegistryNumber": "EC 3.2.1.18",
      "NameOfSubstance": "Neuraminidase"
    },
    {
      "RegistryNumber": "EC 3.2.1.35",
      "NameOfSubstance": "Hyaluronoglucosaminidase"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Adenocarcinoma, Mucinous"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Breast Neoplasms"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Carcinoma in Situ"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Epithelial Cells"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hyaluronoglucosaminidase"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Mucins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neuraminidase"
    }
  ]
}